Not exact matches
Non —
small cell lung cancer may involve genetic aberrations that can be used to direct therapy.
Sarah B. Goldberg, MD, MPH, an assistant professor of medicine at the Yale School of Medicine and Yale
Cancer Center, discusses osimertinib (Tagrisso) for the treatment of patients with non — small cell lung c
Cancer Center, discusses osimertinib (Tagrisso) for the treatment of patients with
non —
small cell lung cancercancer.
The companies have launched a phase II trial of the antibody - drug conjugate, and are also testing it in other solid tumors, including ovarian and
non —
small -
cell lung cancers.
Itraconazole Inhibits Angiogenesis and Tumor Growth in
Non —
Small Cell Lung Cancer.
Navitoclax Enhances the Efficacy of Taxanes in
Non —
Small Cell Lung Cancer Models.
Though commonly associated with breast
cancer, HER2 mutations occur in a
small proportion of
non —
small -
cell lung cancer (NSCLC) patients.
[12]
Cancers that respond the most favorably to checkpoint inhibitors include
non —
small -
cell lung cancer, largely caused by chronic exposure to carcinogens in cigarette smoke, and melanoma, largely caused by exposure to ultraviolet light.
«The TAILOR study draws out attention to the fact that outcomes are poor in second - line treatment of
non —
small -
cell lung cancer, with our available treatments resulting in median progression - free survivals of two or three months,» said Benjamin Solomon, MBBS, PhD, of Peter MacCallum Cancer Centre in Melb
cancer, with our available treatments resulting in median progression - free survivals of two or three months,» said Benjamin Solomon, MBBS, PhD, of Peter MacCallum
Cancer Centre in Melb
Cancer Centre in Melbourne.
The study included patients 18 years of age and older with melanoma,
non —
small -
cell lung cancer (NSCLC), squamous
cell cancer of the head and neck (SCCHN), or pancreatic
cancer.
Bench and mouse studies have shown that the Notch1 gene is a crucial contributor to tumorigenesis in
non —
small -
cell lung cancer (NSCLC).
Durvalumab after Chemoradiotherapy in Stage III
Non —
Small -
Cell Lung Cancer.